Rocket Pharmaceuticals, Inc.

NasdaqGM:RCKT Stock Report

Market Cap: US$1.3b

Rocket Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:RCKT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
21 Nov 24SellUS$144,782Gaurav ShahIndividual11,091US$13.05
21 Nov 24SellUS$15,338Martin WilsonIndividual1,175US$13.05
21 Nov 24SellUS$15,978John MilitelloIndividual1,224US$13.05
21 Nov 24SellUS$59,892Kinnari PatelIndividual4,588US$13.05
31 Oct 24SellUS$15,245John MilitelloIndividual917US$16.63
31 Oct 24SellUS$51,205Mark WhiteIndividual3,080US$16.63
16 Aug 24SellUS$73,812Kinnari PatelIndividual3,989US$18.50
16 Aug 24SellUS$19,004Martin WilsonIndividual1,027US$18.50
16 Aug 24SellUS$178,564Gaurav ShahIndividual9,650US$18.50
16 Aug 24SellUS$19,688John MilitelloIndividual1,064US$18.50
22 Jul 24SellUS$18,688John MilitelloIndividual812US$23.02
08 Jul 24SellUS$61,715Mark WhiteIndividual3,026US$20.40
16 May 24SellUS$24,471Martin WilsonIndividual1,048US$23.35
16 May 24SellUS$25,195John MilitelloIndividual1,079US$23.35
16 May 24SellUS$94,474Kinnari PatelIndividual4,046US$23.35
16 May 24SellUS$228,597Gaurav ShahIndividual9,790US$23.35
22 Apr 24SellUS$19,051John MilitelloIndividual833US$22.87
15 Apr 24SellUS$240,520David SouthwellIndividual10,000US$24.05
08 Apr 24SellUS$308,763Mark WhiteIndividual12,532US$24.64
21 Mar 24SellUS$69,979John MilitelloIndividual2,490US$28.10
21 Mar 24SellUS$7,790,943Simran Investment Group LlcCompany274,000US$28.43
29 Feb 24SellUS$120,257Martin WilsonIndividual4,100US$29.33
16 Feb 24SellUS$604,876Gaurav ShahIndividual20,272US$29.84
16 Feb 24SellUS$96,615John MilitelloIndividual3,238US$29.84
16 Feb 24SellUS$106,701Martin WilsonIndividual3,576US$29.84
16 Feb 24SellUS$212,805Kinnari PatelIndividual7,132US$29.84
22 Jan 24SellUS$17,356John MilitelloIndividual638US$27.20

Insider Trading Volume

Insider Buying: RCKT insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of RCKT?
Owner TypeNumber of SharesOwnership Percentage
Private Companies104,9270.106%
Individual Insiders2,282,5312.31%
Hedge Funds17,687,77217.9%
Institutions78,580,28979.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 84.1% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.4%
RTW Investments, LP
17,687,772US$249.6m0%3.35%
12.3%
Wellington Management Group LLP
11,242,144US$158.6m22.8%0.02%
6.99%
BlackRock, Inc.
6,370,721US$89.9m2.88%no data
6.07%
The Vanguard Group, Inc.
5,536,940US$78.1m-4.68%no data
4.93%
Westfield Capital Management Company, L.P.
4,493,833US$63.4m3.83%0.26%
4.52%
Maverick Capital, Ltd.
4,118,672US$58.1m4.85%1.04%
3.52%
T. Rowe Price Group, Inc.
3,207,781US$45.3m1.21%no data
3.4%
State Street Global Advisors, Inc.
3,102,022US$43.8m11.6%no data
2.36%
Citadel Advisors LLC
2,148,093US$30.3m-23.8%0.03%
2.08%
Janus Henderson Group plc
1,897,340US$26.8m-35%0.01%
1.77%
Geode Capital Management, LLC
1,617,866US$22.8m0.89%no data
1.63%
Frazier Life Sciences Management, LP
1,485,630US$21.0m-4.84%0.83%
1.61%
Tavistock Life Sciences
1,466,051US$20.7m0%1.31%
1.52%
Pictet Asset Management Limited
1,386,705US$19.6m13.1%0.02%
1.32%
Millennium Management LLC
1,202,495US$17.0m1,040%0.01%
1.22%
Gaurav Shah
1,113,566US$15.7m-0.99%no data
1.21%
Novo Holdings A/S
1,100,000US$15.5m0%0.01%
1.21%
Cowen Inc,Private Banking and Investment Banking Investments
1,100,000US$15.5m0%0.43%
1.17%
BioImpact Capital LLC
1,066,373US$15.0m0%2.36%
1.06%
Franklin Resources, Inc.
969,547US$13.7m-13.2%no data
1.02%
Perceptive Advisors LLC
931,851US$13.1m-25.3%0.28%
1%
Dimensional Fund Advisors LP
912,605US$12.9m-3.55%no data
0.97%
Baron Capital Group, Inc.
884,341US$12.5m-9.7%0.03%
0.89%
Russell Investment Management, LLC
812,310US$11.5m19.9%0.01%
0.89%
Medical Strategy GmbH, Asset Management Arm
808,816US$11.4m0%0.67%